Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China
- Conditions
- Cancer of Unknown Primary Site
- Registration Number
- NCT04952103
- Lead Sponsor
- Fudan University
- Brief Summary
This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Had a diagnosis of cancer of unknown primary (CUP) after a standard evaluation .
- Prepared to receive first-line therapy for CUP
Read More
Exclusion Criteria
- Patients who had previously received systemic therapy for CUP
- Previous history of other cancers, except cervix cancer or basal cell carcinoma of the skin that has been cured
- The investigator considered that there were contraindications to treatment or were not appropriate to participate in this study
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival (PFS) 8 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Fudan University Shanghai Cencer Center
🇨🇳Shanghai, Shanghai, China